EditorialKommentarOpen Access
A new path to alternative lengthening of telomeres?
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noad054 ↗Kurz gefasst
Editorial in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Oren J Becher. Beteiligte Einrichtung: Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Telomerase, Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
TelomeraseGliomaHumansChildDNA Mismatch RepairTelomereMutationX-linked Nuclear Protein
Substanzen
TelomeraseATRX protein, humanX-linked Nuclear Protein
Autor:innen und Institutionen
- Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Oren J Becher
Förderung
- NCI NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Becher, O. J. (2023). A new path to alternative lengthening of telomeres?. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad054
Vancouver
Becher OJ. A new path to alternative lengthening of telomeres?. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad054
BibTeX
@article{Becher2023,
author = {Becher, Oren J},
title = {A new path to alternative lengthening of telomeres?},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noad054}
}
EUVIMED